Gerstner, Elizabeth, David Izquierdo, Yangming Ou, Kyree Emblem, Xuezhu Cai, Xiao Da, Dan Chonde, et al. 2015. “NIMG-29 Radiolabeled Temozolomide Can Measure Bevacizumab Induced Vascular Modulation in Patients With Recurrent GBM”. Neuro-oncology 17 (suppl\_5): v160–v160.